| Structure |
Chemical Name |
CAS |
MF |
 |
Pitavastatin Impurity 75 |
|
|
 |
Febuxostat Impurity 100 |
|
|
 |
Febuxostat Impurity 101 |
|
|
 |
Febuxostat Impurity 105 |
|
|
![(S)-10-amino-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid](/) |
(S)-10-amino-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
|
 |
Ticagrelor Impurity 129 |
1381841-36-6 |
C15H19NO3 |
 |
Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)- |
136819-59-5 |
C13H10N2O3 |
![1,3-Benzenediamine, 4-methyl-N3-[4-methyl-6-(3-pyridinyl)-2-pyrimidinyl]-](/CAS/20200611/GIF/1032314-73-0.gif) |
1,3-Benzenediamine, 4-methyl-N3-[4-methyl-6-(3-pyridinyl)-2-pyrimidinyl]- |
1032314-73-0 |
C17H17N5 |
![5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid](/) |
5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid |
|
|
 |
Teneligliptin Impurity 17 |
|
|
 |
1(3H)-Isobenzofuranone, 3-(1-methylpropyl)- |
261783-87-3 |
C12H14O2 |
 |
2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5S)- |
2514942-86-8 |
C13H15NO4 |
![6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-, (5S,6E)-](/CAS/20200611/GIF/1803023-43-9.gif) |
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-, (5S,6E)- |
1803023-43-9 |
C22H26FN3O6S |
 |
Drug impurity detection and analysis |
|
|
 |
Peramivir Impurity 20 |
|
|
 |
Ambroxol Impurity 33 |
199472-91-8 |
C13H20N2O |
 |
Bilastine Impurity 12 |
1638785-18-8 |
C30H42N4O3 |
 |
RocuroniuMbroMide iMpurity F |
|
|
 |
Oseltamivir Impurity 3 |
|
|
 |
Phenylephrine Impurity 2 |
|
C9H13NO2 |
 |
Pitavastatin Impurity 23 |
1467166-39-7 |
C28H28FNO4 |
 |
Pregabalin Impurity 24 |
|
|
 |
Rocuronium Bromide Impurity 11 |
|
|
 |
Rocuronium Bromide Impurity 24 |
|
|
 |
Rosuvastatin EP Impurity L |
|
|
 |
Timolol EP Impurity J |
|
|
 |
Trimetazidine Impurity 7 |
|
|
 |
Cefazolin Impurity L |
|
|
 |
Ceftazidime hetero trans oxidation Impurity |
|
|
 |
Regorafenib Impurity 17 |
|
|
 |
Ropivacaine Impurity 45 |
2726971-51-1 |
|
 |
Sildenafil Impurity 17 |
|
C22H30N6O4S |
 |
Sugammadex sodium Org199074-1 Impurity |
|
|
 |
Sugammadex sodium Org238832-1 Impurity |
|
|
 |
Butyphthalide impurity 27 |
33704-16-4 |
C12H12O5 |
 |
Butyphthalide impurity 35 |
|
|
 |
Canagliflozin Impurity 31 |
|
|
 |
Celecoxib Impurity 21 |
2055787-31-8 |
C17H12F3N3O3S |
 |
Emtricitabine Impurity CFTU2 |
|
|
 |
Febuxostat Impurity 88 |
|
|
 |
Gefitinib Impurity S |
|
|
 |
Ibrutinib Impurity 15 |
1288338-97-5 |
C47H46N12O3 |
 |
Ribavirin IMpurity E |
58151-90-9 |
C15H16N4O6 |
![3-メトキシ-5,6,9,10,11,12-ヘキサヒドロ-11-メチル-4aH-ベンゾフロ[3a,3,2-ef][2]ベンゾアゼピン](/CAS/GIF/664995-65-7.gif) |
3-メトキシ-5,6,9,10,11,12-ヘキサヒドロ-11-メチル-4aH-ベンゾフロ[3a,3,2-ef][2]ベンゾアゼピン |
664995-65-7 |
C17H19NO2 |
 |
ジエチルカルバミン酸クロロメチル |
133217-92-2 |
C6H12ClNO2 |
 |
トリメタジジンN-カルボン酸エチルエステル |
53531-01-4 |
C17H26N2O5 |
 |
(S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione |
148857-42-5 |
C11H10ClNO3 |
 |
Loratadine IMpurity C |
|
C22H23ClN2O2 |
 |
Metoprolol IMpurity C |
|
C15H25NO3 |
 |
para-Hydroxy L-Milnacipran |
688738-11-6 |
C15H22N2O2 |
 |
Varenicline Impurity 9 |
|
|
 |
(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
|
|
![1-Pyrrolidinecarboxamide, N-[5-[(2S)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)-](/CAS/20210111/GIF/2409590-08-3.gif) |
1-Pyrrolidinecarboxamide, N-[5-[(2S)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)- |
2409590-08-3 |
C21H22F2N6O2 |
 |
Sertraline Impurity 20 |
1498236-91-1 |
C16H14Cl2O |
 |
LCZ696(valsartan + sacubitril) impurity 34 |
|
|
 |
Lenvatinib Impurity 27 |
|
|
 |
Montelukast sodium impurity H |
|
|
 |
Regorafenib Impurity 25 |
|
|
 |
Regorafenib Impurity 33 |
|
|
 |
Sitafloxacin Impurity ZZ-A-02 |
|
|
 |
Solifenacin impurity 19 |
1422505-78-9 |
C17H17NO |
 |
Tofacitinib Impurity 93 |
|
|
 |
Topiroxostat Impurity 30 |
|
|
 |
Sitafloxacin Impurity 8 |
|
|
 |
Budesonide Impurity 7 |
3949-79-9 |
C23H28O7 |
 |
Diazepam Impurity 1 |
36020-94-7 |
C16H15ClN2O2 |
 |
Rosuvastatin Related Compound 8 |
521974-01-6 |
C13H23ClO4 |
 |
Aztreonam Impurity 8 |
|
|
 |
(1s,4s)-4-((2-amino-4-bromobenzyl)amino)cyclohexan-1-ol hydrochloride |
|
C13H20BrClN2O |
 |
Pitavastatin Impurity 18 Sodium Salt |
2276678-27-2 |
C25H25FNNaO5 |
 |
Moxifloxacin Impurity 67 |
1430075-14-1 |
C10H16ClNO3 |
 |
Landiolol impurity |
|
|
 |
Irinotecan Impurity K |
|
|
 |
Palbociclib Impurity 28 |
|
|
 |
Vildagliptin Impurity 37 |
|
|
 |
Tazobactam Impurity B |
115546-66-2 |
C10H12N4O5S |
 |
Brexpiprazole Impurity 20 |
105685-34-5 |
C12H14N2O |
 |
Pralatrexate Impurity 13 |
|
|
 |
Pralatrexate Impurity 18 |
|
|
 |
Pitavastatin Impurity 50 |
|
|
 |
Pitavastatin Impurity 58 |
|
|
 |
Lenvatinib Impurity 41 |
|
|
 |
Tazobactam Impurity 12 |
|
|
 |
Tofacitinib Impurity 103 |
|
|
 |
Posaconazole impurity 69 |
|
|
 |
Crisaborole Impurity 3 |
|
|
 |
Canagliflozin Impurity 59 |
|
|
 |
Canagliflozin Impurity 64 |
|
|
 |
Hydroxychloroquine Impurity I |
|
|
 |
Sitafloxacin Impurity 22 |
|
|
 |
Levetiracetam Impurity 24 |
|
|
 |
Selexipag Impurity 5 |
2928611-79-2 |
C22H23N3O3 |
 |
Levosimendan Impurity 11 |
|
|
 |
Cabozantinib impurity O |
|
|
![(41S,12S,13aS)-12-(ethoxycarbonyl)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydroindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine 4(1H)-oxide](/CAS/20210111/GIF/52341-36-3.gif) |
(41S,12S,13aS)-12-(ethoxycarbonyl)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydroindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine 4(1H)-oxide |
52341-36-3 |
C22H28N2O4 |
 |
Rotigotine Impurity 5 |
|
|
 |
Rotigotine Impurity 10 |
|
|
 |
(2S)-シクロペンチル(ヒドロキシ)(フェニル)酢酸 |
64471-43-8 |
C13H16O3 |
 |
Olprinone Impurity 6 |
|
|
 |
Trenbolone Acetate Process Impurity 4 |
5218-51-9 |
C18H24O2 |